Avricore Health (AVCRF) Gross Margin (2009 - 2025)

Avricore Health has disclosed Gross Margin across 15 years of filings, most recently posting 139.6% for Q3 2025.

• In Q3 2025, Gross Margin fell 17598.0% year-over-year to 139.6%; the TTM figure through Sep 2025 stood at 39.71% (up 173.0% YoY), while the FY2025 annual figure was 44.63%, up 534.0% from the prior year.
• Gross Margin grew to 139.6% in Q3 2025, from 167.63% in the prior quarter.
• Over the last five years, Gross Margin for AVCRF reached as high as 79.78% in Q1 2025 and fell as low as 167.63% in Q2 2025.
• The 5-year median for Gross Margin is 32.88% (2022), against an average of 11.41%.
• Annual changes were most pronounced in 2022 — Gross Margin soared 5249 bps — and 2025, when it tumbled 20310 bps.
• A 5-year view of Gross Margin shows it stood at 26.48% in 2021, then slumped by 35 bps to 17.28% in 2022, then soared by 114 bps to 37.02% in 2023, then slipped by 2 bps to 36.38% in 2024, then sank by 484 bps to 139.6% in 2025.
• According to Business Quant data, Gross Margin over the past three periods registered 139.6%, 167.63%, and 79.78% for Q3 2025, Q2 2025, and Q1 2025 respectively.